310 related articles for article (PubMed ID: 9924899)
1. NMDA-receptor activity visualized with (S)-[N-methyl-11C]ketamine and positron emission tomography in patients with medial temporal lobe epilepsy.
Kumlien E; Hartvig P; Valind S; Oye I; Tedroff J; Långström B
Epilepsia; 1999 Jan; 40(1):30-7. PubMed ID: 9924899
[TBL] [Abstract][Full Text] [Related]
2. Is 11C-flumazenil PET superior to 18FDG PET and 123I-iomazenil SPECT in presurgical evaluation of temporal lobe epilepsy?
Debets RM; Sadzot B; van Isselt JW; Brekelmans GJ; Meiners LC; van Huffelen AO; Franck G; van Veelen CW
J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):141-50. PubMed ID: 9048714
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting bilateral temporal lobe hypometabolism on 18F-FDG PET brain scan in unilateral medial temporal lobe epilepsy.
Tepmongkol S; Srikijvilaikul T; Vasavid P
Epilepsy Behav; 2013 Nov; 29(2):386-9. PubMed ID: 24074882
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the intracarotid amobarbital procedure and interictal cerebral 18-fluorodeoxyglucose positron emission tomography scans in refractory temporal lobe epilepsy.
Salanova V; Morris HH; Rehm P; Wyllie E; Dinner DS; Lüders H; Gilmore-Pollak W
Epilepsia; 1992; 33(4):635-8. PubMed ID: 1628576
[TBL] [Abstract][Full Text] [Related]
5. Glucose and [11C]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy.
Juhász C; Nagy F; Watson C; da Silva EA; Muzik O; Chugani DC; Shah J; Chugani HT
Neurology; 1999 Dec; 53(9):2037-45. PubMed ID: 10599778
[TBL] [Abstract][Full Text] [Related]
6. Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET study.
Werhahn KJ; Landvogt C; Klimpe S; Buchholz HG; Yakushev I; Siessmeier T; Müller-Forell W; Piel M; Rösch F; Glaser M; Schreckenberger M; Bartenstein P
Epilepsia; 2006 Aug; 47(8):1392-6. PubMed ID: 16922886
[TBL] [Abstract][Full Text] [Related]
7. Metabolic changes of subcortical structures in intractable focal epilepsy.
Benedek K; Juhász C; Muzik O; Chugani DC; Chugani HT
Epilepsia; 2004 Sep; 45(9):1100-5. PubMed ID: 15329075
[TBL] [Abstract][Full Text] [Related]
8. Thalamic hypometabolism on 18FDG-positron emission tomography in medial temporal lobe epilepsy.
Hashiguchi K; Morioka T; Yoshida F; Kawamura T; Miyagi Y; Kuwabara Y; Sasaki M; Koga H; Nagata S; Sasaki T
Neurol Res; 2007 Mar; 29(2):215-22. PubMed ID: 17439707
[TBL] [Abstract][Full Text] [Related]
9. In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy.
Henry TR; Frey KA; Sackellares JC; Gilman S; Koeppe RA; Brunberg JA; Ross DA; Berent S; Young AB; Kuhl DE
Neurology; 1993 Oct; 43(10):1998-2006. PubMed ID: 8413957
[TBL] [Abstract][Full Text] [Related]
10. PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy.
Toczek MT; Carson RE; Lang L; Ma Y; Spanaki MV; Der MG; Fazilat S; Kopylev L; Herscovitch P; Eckelman WC; Theodore WH
Neurology; 2003 Mar; 60(5):749-56. PubMed ID: 12629228
[TBL] [Abstract][Full Text] [Related]
11. Correlations of interictal FDG-PET metabolism and ictal SPECT perfusion changes in human temporal lobe epilepsy with hippocampal sclerosis.
Nelissen N; Van Paesschen W; Baete K; Van Laere K; Palmini A; Van Billoen H; Dupont P
Neuroimage; 2006 Aug; 32(2):684-95. PubMed ID: 16762567
[TBL] [Abstract][Full Text] [Related]
12. In vivo imaging of muscarinic cholinergic receptors in temporal lobe epilepsy with a new PET tracer: [76Br]4-bromodexetimide.
Dupont S; Semah F; Loc'h C; Strijckmans V; Baulac M; Samson Y; Mazière B
J Nucl Med; 1999 Jun; 40(6):935-41. PubMed ID: 10452308
[TBL] [Abstract][Full Text] [Related]
13. Thalamic glucose metabolism in temporal lobe epilepsy measured with 18F-FDG positron emission tomography (PET).
Khan N; Leenders KL; Hajek M; Maguire P; Missimer J; Wieser HG
Epilepsy Res; 1997 Oct; 28(3):233-43. PubMed ID: 9332888
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography with [11C]deuterium-deprenyl in temporal lobe epilepsy.
Kumlien E; Bergström M; Lilja A; Andersson J; Szekeres V; Westerberg CE; Westerberg G; Antoni G; Långström B
Epilepsia; 1995 Jul; 36(7):712-21. PubMed ID: 7555990
[TBL] [Abstract][Full Text] [Related]
15. Comparison of ictal SPECT and interictal PET in the presurgical evaluation of temporal lobe epilepsy.
Ho SS; Berkovic SF; Berlangieri SU; Newton MR; Egan GF; Tochon-Danguy HJ; McKay WJ
Ann Neurol; 1995 Jun; 37(6):738-45. PubMed ID: 7778847
[TBL] [Abstract][Full Text] [Related]
16. Temporal lobe epilepsy with sensory aura: interictal glucose hypometabolism.
Wunderlich G; Schüller MF; Ebner A; Holthausen H; Tuxhorn I; Witte OW; Seitz RJ
Epilepsy Res; 2000 Feb; 38(2-3):139-49. PubMed ID: 10642042
[TBL] [Abstract][Full Text] [Related]
17. Correlation of severity of FDG-PET hypometabolism and interictal regional delta slowing in temporal lobe epilepsy.
Erbayat Altay E; Fessler AJ; Gallagher M; Attarian HP; Dehdashti F; Vahle VJ; Ojemann J; Dowling JL; Gilliam FG
Epilepsia; 2005 Apr; 46(4):573-6. PubMed ID: 15816953
[TBL] [Abstract][Full Text] [Related]
18. Is amygdalohippocampectomy really selective in medial temporal lobe epilepsy? A study using positron emission tomography with (18)fluorodeoxyglucose.
Dupont S; Croizé AC; Semah F; Hasboun D; Samson Y; Clémenceau S; Baulac M
Epilepsia; 2001 Jun; 42(6):731-40. PubMed ID: 11422327
[TBL] [Abstract][Full Text] [Related]
19. Quantification of mu and non-mu opiate receptors in temporal lobe epilepsy using positron emission tomography.
Mayberg HS; Sadzot B; Meltzer CC; Fisher RS; Lesser RP; Dannals RF; Lever JR; Wilson AA; Ravert HT; Wagner HN
Ann Neurol; 1991 Jul; 30(1):3-11. PubMed ID: 1656846
[TBL] [Abstract][Full Text] [Related]
20. Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [
Finnema SJ; Toyonaga T; Detyniecki K; Chen MK; Dias M; Wang Q; Lin SF; Naganawa M; Gallezot JD; Lu Y; Nabulsi NB; Huang Y; Spencer DD; Carson RE
Epilepsia; 2020 Oct; 61(10):2183-2193. PubMed ID: 32944949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
